POWER OF BLOGS

Insight Center: Blogs

Stanford Patent Found Invalid in IPR proceedings but Licensee's IP Survives

Author: Thomas J. Engellenner

11/30/2014

Read the full post at Post-Grant Counsel

In a decision this month (IPR2013-00308), the Patent Trial and Appeal Board (PTAB) has ruled against Stanford University’s patented method for detecting Down’s syndrome and other chromosomal defects, finding all of the challenged claims 1-13 invalid.